Treatment of recurrent carcinoma of the vulva

From 1960 to 1976, 29 patients out of a total 164 were evaluated at the University of Wisconsin Center for Health Sciences for recurrent squamous cell carcinoma of the vulva. Additional surgery or irradiation was administered to 93%. The majority of patients (18) presented with recurrent disease inv...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Gynecologic oncology 1979-10, Vol.8 (2), p.180-184
Hauptverfasser: Buchler, Dolores A., Kline, Joyce C., Tunca, Josh C., Carr, William F.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 184
container_issue 2
container_start_page 180
container_title Gynecologic oncology
container_volume 8
creator Buchler, Dolores A.
Kline, Joyce C.
Tunca, Josh C.
Carr, William F.
description From 1960 to 1976, 29 patients out of a total 164 were evaluated at the University of Wisconsin Center for Health Sciences for recurrent squamous cell carcinoma of the vulva. Additional surgery or irradiation was administered to 93%. The majority of patients (18) presented with recurrent disease involving only the perineum. The average survival following surgery was 43 months, or after irradiation, 26 months. Many of these patients (73%) obtained local control of their disease. Recurrent tumor involved the groins or pelvis in the remaining patients (9). Seven of these patients obtained good palliation and/or local control following surgery or irradiation. The average survival for the entire group was 24 months with 2 patients NED at 4 and 13 years.
doi_str_mv 10.1016/0090-8258(79)90023-4
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_74788833</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>0090825879900234</els_id><sourcerecordid>74788833</sourcerecordid><originalsourceid>FETCH-LOGICAL-c355t-6802d1c5737ac2cbf725f1d6cd33e816f6e2b13d128eab64b415bba16e9d206f3</originalsourceid><addsrcrecordid>eNp9kE1LAzEQhoNYtFZ_gR56Ej2sZpJNNrkIpfgFBS_1HLLJLK7sR012C_57d9vSo6dh5n3nHeYh5AboA1CQj5Rqmigm1F2m7zWljCfpCZkC1SKRSuhTMj1azslFjN-UUk6BnZGJBiFgSpJ1QNvV2HTztpgHdH0IY-NscGXT1nYcd1843_bV1l6SSWGriFeHOiOfL8_r5Vuy-nh9Xy5WieNCdMNtyjw4kfHMOubyImOiAC-d5xwVyEIiy4F7YAptLtM8BZHnFiRqz6gs-Izc7nM3of3pMXamLqPDqrINtn00WZoppTgfjOne6EIbY8DCbEJZ2_BrgJqRkRkBmBGAybTZMTLpsHZ9yO_zGv1xaQdlUJ_2Kg4vbksMJroSG4e-HAB1xrfl__F_qE90jQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>74788833</pqid></control><display><type>article</type><title>Treatment of recurrent carcinoma of the vulva</title><source>Elsevier ScienceDirect Journals Complete - AutoHoldings</source><source>MEDLINE</source><creator>Buchler, Dolores A. ; Kline, Joyce C. ; Tunca, Josh C. ; Carr, William F.</creator><creatorcontrib>Buchler, Dolores A. ; Kline, Joyce C. ; Tunca, Josh C. ; Carr, William F.</creatorcontrib><description>From 1960 to 1976, 29 patients out of a total 164 were evaluated at the University of Wisconsin Center for Health Sciences for recurrent squamous cell carcinoma of the vulva. Additional surgery or irradiation was administered to 93%. The majority of patients (18) presented with recurrent disease involving only the perineum. The average survival following surgery was 43 months, or after irradiation, 26 months. Many of these patients (73%) obtained local control of their disease. Recurrent tumor involved the groins or pelvis in the remaining patients (9). Seven of these patients obtained good palliation and/or local control following surgery or irradiation. The average survival for the entire group was 24 months with 2 patients NED at 4 and 13 years.</description><identifier>ISSN: 0090-8258</identifier><identifier>EISSN: 1095-6859</identifier><identifier>DOI: 10.1016/0090-8258(79)90023-4</identifier><identifier>PMID: 91551</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Carcinoma, Squamous Cell - therapy ; Female ; Humans ; Palliative Care ; Pelvic Neoplasms - therapy ; Perineum ; Radioisotope Teletherapy ; Recurrence ; Vulvar Neoplasms - therapy</subject><ispartof>Gynecologic oncology, 1979-10, Vol.8 (2), p.180-184</ispartof><rights>1979</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c355t-6802d1c5737ac2cbf725f1d6cd33e816f6e2b13d128eab64b415bba16e9d206f3</citedby><cites>FETCH-LOGICAL-c355t-6802d1c5737ac2cbf725f1d6cd33e816f6e2b13d128eab64b415bba16e9d206f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/0090-8258(79)90023-4$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3549,27923,27924,45994</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/91551$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Buchler, Dolores A.</creatorcontrib><creatorcontrib>Kline, Joyce C.</creatorcontrib><creatorcontrib>Tunca, Josh C.</creatorcontrib><creatorcontrib>Carr, William F.</creatorcontrib><title>Treatment of recurrent carcinoma of the vulva</title><title>Gynecologic oncology</title><addtitle>Gynecol Oncol</addtitle><description>From 1960 to 1976, 29 patients out of a total 164 were evaluated at the University of Wisconsin Center for Health Sciences for recurrent squamous cell carcinoma of the vulva. Additional surgery or irradiation was administered to 93%. The majority of patients (18) presented with recurrent disease involving only the perineum. The average survival following surgery was 43 months, or after irradiation, 26 months. Many of these patients (73%) obtained local control of their disease. Recurrent tumor involved the groins or pelvis in the remaining patients (9). Seven of these patients obtained good palliation and/or local control following surgery or irradiation. The average survival for the entire group was 24 months with 2 patients NED at 4 and 13 years.</description><subject>Carcinoma, Squamous Cell - therapy</subject><subject>Female</subject><subject>Humans</subject><subject>Palliative Care</subject><subject>Pelvic Neoplasms - therapy</subject><subject>Perineum</subject><subject>Radioisotope Teletherapy</subject><subject>Recurrence</subject><subject>Vulvar Neoplasms - therapy</subject><issn>0090-8258</issn><issn>1095-6859</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1979</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1LAzEQhoNYtFZ_gR56Ej2sZpJNNrkIpfgFBS_1HLLJLK7sR012C_57d9vSo6dh5n3nHeYh5AboA1CQj5Rqmigm1F2m7zWljCfpCZkC1SKRSuhTMj1azslFjN-UUk6BnZGJBiFgSpJ1QNvV2HTztpgHdH0IY-NscGXT1nYcd1843_bV1l6SSWGriFeHOiOfL8_r5Vuy-nh9Xy5WieNCdMNtyjw4kfHMOubyImOiAC-d5xwVyEIiy4F7YAptLtM8BZHnFiRqz6gs-Izc7nM3of3pMXamLqPDqrINtn00WZoppTgfjOne6EIbY8DCbEJZ2_BrgJqRkRkBmBGAybTZMTLpsHZ9yO_zGv1xaQdlUJ_2Kg4vbksMJroSG4e-HAB1xrfl__F_qE90jQ</recordid><startdate>197910</startdate><enddate>197910</enddate><creator>Buchler, Dolores A.</creator><creator>Kline, Joyce C.</creator><creator>Tunca, Josh C.</creator><creator>Carr, William F.</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>197910</creationdate><title>Treatment of recurrent carcinoma of the vulva</title><author>Buchler, Dolores A. ; Kline, Joyce C. ; Tunca, Josh C. ; Carr, William F.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c355t-6802d1c5737ac2cbf725f1d6cd33e816f6e2b13d128eab64b415bba16e9d206f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1979</creationdate><topic>Carcinoma, Squamous Cell - therapy</topic><topic>Female</topic><topic>Humans</topic><topic>Palliative Care</topic><topic>Pelvic Neoplasms - therapy</topic><topic>Perineum</topic><topic>Radioisotope Teletherapy</topic><topic>Recurrence</topic><topic>Vulvar Neoplasms - therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Buchler, Dolores A.</creatorcontrib><creatorcontrib>Kline, Joyce C.</creatorcontrib><creatorcontrib>Tunca, Josh C.</creatorcontrib><creatorcontrib>Carr, William F.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Gynecologic oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Buchler, Dolores A.</au><au>Kline, Joyce C.</au><au>Tunca, Josh C.</au><au>Carr, William F.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Treatment of recurrent carcinoma of the vulva</atitle><jtitle>Gynecologic oncology</jtitle><addtitle>Gynecol Oncol</addtitle><date>1979-10</date><risdate>1979</risdate><volume>8</volume><issue>2</issue><spage>180</spage><epage>184</epage><pages>180-184</pages><issn>0090-8258</issn><eissn>1095-6859</eissn><abstract>From 1960 to 1976, 29 patients out of a total 164 were evaluated at the University of Wisconsin Center for Health Sciences for recurrent squamous cell carcinoma of the vulva. Additional surgery or irradiation was administered to 93%. The majority of patients (18) presented with recurrent disease involving only the perineum. The average survival following surgery was 43 months, or after irradiation, 26 months. Many of these patients (73%) obtained local control of their disease. Recurrent tumor involved the groins or pelvis in the remaining patients (9). Seven of these patients obtained good palliation and/or local control following surgery or irradiation. The average survival for the entire group was 24 months with 2 patients NED at 4 and 13 years.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>91551</pmid><doi>10.1016/0090-8258(79)90023-4</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0090-8258
ispartof Gynecologic oncology, 1979-10, Vol.8 (2), p.180-184
issn 0090-8258
1095-6859
language eng
recordid cdi_proquest_miscellaneous_74788833
source Elsevier ScienceDirect Journals Complete - AutoHoldings; MEDLINE
subjects Carcinoma, Squamous Cell - therapy
Female
Humans
Palliative Care
Pelvic Neoplasms - therapy
Perineum
Radioisotope Teletherapy
Recurrence
Vulvar Neoplasms - therapy
title Treatment of recurrent carcinoma of the vulva
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T05%3A24%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Treatment%20of%20recurrent%20carcinoma%20of%20the%20vulva&rft.jtitle=Gynecologic%20oncology&rft.au=Buchler,%20Dolores%20A.&rft.date=1979-10&rft.volume=8&rft.issue=2&rft.spage=180&rft.epage=184&rft.pages=180-184&rft.issn=0090-8258&rft.eissn=1095-6859&rft_id=info:doi/10.1016/0090-8258(79)90023-4&rft_dat=%3Cproquest_cross%3E74788833%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=74788833&rft_id=info:pmid/91551&rft_els_id=0090825879900234&rfr_iscdi=true